NCT05019495 Optimizing Tobacco Treatment Delivery for People Living With HIV
| NCT ID | NCT05019495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 231 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 231 participants in total. It began in 2021-12-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.
Eligibility Criteria
Inclusion Criteria: * Age 21 and older * Current diagnosis of HIV * Current smoker (defined as self-report of current smoking) * Willing to be randomized * English speaking Exclusion Criteria: * Currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking nicotine replacement therapy or other cessation medications, enrolled in the Quitline, or in another study) * Currently imprisoned * Pregnant women * Non-English speaking persons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05019495 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05019495 currently recruiting?
Yes, NCT05019495 is actively recruiting participants. Contact the research team at morone@musc.edu for enrollment information.
Where is the NCT05019495 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT05019495 clinical trial?
NCT05019495 is sponsored by Medical University of South Carolina. The trial plans to enroll 231 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.